Expert Opinion on Biological Therapy : Impact Factor & More
eISSN: 1744-7682pISSN: 1471-2598
Share this on:
Aims and Scope of Expert Opinion on Biological Therapy
Expert Opinion on Biological Therapy is a monthly peer-reviewed medical journal covering research on all aspects of biological therapy, including gene therapy and gene transfer technologies, therapeutic peptides and proteins, vaccines and antibodies, and cell- and tissue-based therapies. The journal is published by Taylor & Francis and the editor-in-chief is Michael Morse (Duke University Hospital). The journal was established in 2001 and according to the Journal Citation Reports, it has a 2017 impact factor of 3.974. The journal is also indexed in MEDLINE. Less
Key Metrics
CiteScore 
7.2
Eigenfactor
0.005 - 0.01
H-Index
96
Impact Factor
< 5
SJR
Q1Pharmacology
SNIP
1.01
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Expert Opinion on Biological Therapy
Expert Opinion on Biological Therapy Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | TAYLOR & FRANCIS LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2001 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Expert Opinion on Biological Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Expert Opinion on Biological Therapy
Emerging strategies for the prevention and management of chronic graft-versus-host disease
- 4 May 2026
- Expert Opinion on Biological Therapy
Next-generation CAR-NK cell therapy for glioblastoma: strategies to overcome antigen escape and the immunosuppressive tumor microenvironment
- 4 May 2026
- Expert Opinion on Biological Therapy
Comparing the efficacy and safety of biosimilar BAT2506 with reference golimumab in patients with active psoriatic arthritis: 24-week results of a phase 3, multicenter, double-blind, randomized, parallel-group study
- 4 May 2026
- Expert Opinion on Biological Therapy
Comparability of aflibercept biosimilar with reference aflibercept in diabetic macular edema: subgroup analysis of the pivotal Phase-III insight randomized clinical trial
- 4 May 2026
- Expert Opinion on Biological Therapy
An evaluation of telisotuzumab vedotin for the treatment of non-squamous non-small cell lung cancer
- 4 May 2026
- Expert Opinion on Biological Therapy
Immunomodulator therapies in pandemics: lessons from COVID-19 and a blueprint for future outbreaks
- 4 May 2026
- Expert Opinion on Biological Therapy
Emerging strategies for the prevention and management of chronic graft-versus-host disease
- 4 May 2026
- Expert Opinion on Biological Therapy
Next-generation CAR-NK cell therapy for glioblastoma: strategies to overcome antigen escape and the immunosuppressive tumor microenvironment
- 4 May 2026
- Expert Opinion on Biological Therapy
Comparing the efficacy and safety of biosimilar BAT2506 with reference golimumab in patients with active psoriatic arthritis: 24-week results of a phase 3, multicenter, double-blind, randomized, parallel-group study
- 4 May 2026
- Expert Opinion on Biological Therapy
Comparability of aflibercept biosimilar with reference aflibercept in diabetic macular edema: subgroup analysis of the pivotal Phase-III insight randomized clinical trial
- 4 May 2026
- Expert Opinion on Biological Therapy
An evaluation of telisotuzumab vedotin for the treatment of non-squamous non-small cell lung cancer
- 4 May 2026
- Expert Opinion on Biological Therapy
Immunomodulator therapies in pandemics: lessons from COVID-19 and a blueprint for future outbreaks
- 4 May 2026
- Expert Opinion on Biological Therapy
FAQs on Expert Opinion on Biological Therapy
How long has Expert Opinion on Biological Therapy been actively publishing? 
What is the publishing frequency of Expert Opinion on Biological Therapy?
How many articles did Expert Opinion on Biological Therapy publish last year?
What is the eISSN & pISSN for Expert Opinion on Biological Therapy?
What is Citescore for Expert Opinion on Biological Therapy?
What is the H Index for Expert Opinion on Biological Therapy ?
What is SNIP score for Expert Opinion on Biological Therapy?
What is the SJR for Expert Opinion on Biological Therapy?
Who is the publisher of Expert Opinion on Biological Therapy?
